OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2016
Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.
Transparent communications, both qualitative and quantitative data, and a clear understanding of each other’s needs are keys to collaborating on better product quality.
For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
Only half of new drugs make it past Phase III. Adopting best practices and collaborating more closely with contract research organizations can help ensure success.
Despite the move to more strategic partnerships, research shows that tactical outsourcing is still alive and well.
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies.
Today’s analytical laboratory equipment reflects the realities of downsizing, outsourcing, and the need for speed.
Keith Moore, vice-president of analytical services, Metrics Contract Services discusses gains use in dissolution testing.